Frequency Electronics Inc: Form 10-Q for the period ended Jan 31, 2017
Filed with the SEC on Mar 17, 2017 and accepted by EDGAR at Mar 17, 2017, 16:47 ET.
Management's discussion and analysis
As filed, 26,486 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
The statements in this quarterly report on Form 10-Q regarding future earnings and operations and other statements relating to the future constitute “forward-looking” statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “could,” “should,” “would,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “objective,” “seek,” “strive,” “might,” “likely result,” “build,” “grow,” “plan,” “goal,” “expand,” “position,” or similar words, or the negatives of these words, or similar terminology, identify forward-looking statements. These statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties, and a number of factors could cause the Company’s actual results to differ materially from those expressed in the forward-looking statements referred to above. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, competitive developments, changes in manufacturing and transportation costs, changes in contractual terms, the availability of capital, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which relate only to events as of the date on which the statements are made and which reflect management’s analysis, judgments, belief, or expectation only as of such date. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this report.
Critical Accounting Policies and Estimates
The Company’s significant accounting policies are described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2016. The Company believes its most critical accounting policies to be the recognition of revenue and costs on production contracts and the valuation of inventory. Each of these areas requires the Company to make use of reasoned estimates including estimating the cost to complete a contract, the realizable value of its inventory or the market value of its products. Changes in estimates can have a material impact on the Company’s financial position and results of operations.
Revenue Recognition
Revenues under larger, long-term contracts which generally require billings based on achievement of milestones rather than delivery of product, are reported in operating results using the percentage of completion method. On fixed-price contracts, which are typical for commercial and U.S. Government satellite programs and other long-term U.S. Government projects, and which require initial design and development of the product, revenue is recognized on the cost-to-cost method. Under this method, revenue is recorded based upon the ratio that incurred costs bear to total estimated contract costs with related cost of sales recorded as the costs are incurred. Each month management reviews estimated contract costs through a process of aggregating actual costs incurred and estimating additional costs to completion based upon the current available information and status of the contract. The effect of any change in the estimated gross margin percentage for a contract is reflected in revenues in the period in which the change is known. Provisions for anticipated losses on contracts are made in the period in which they become determinable.
On production-type orders, revenue is recorded as units are delivered with the related cost of sales recognized on each shipment based upon a percentage of estimated final program costs.
Changes in job performance on long-term contracts and production-type orders may result in revisions to costs and income and are recognized in the period in which revisions are determined to be required. Provisions for anticipated losses on customer orders are made in the period in which they become determinable.
For customer orders in the Company’s Gillam-FEI and FEI-Zyfer segments or smaller contracts or orders in the FEI-NY segment, sales of products and services to customers are reported in operating results based upon (i) shipment of the product or (ii) performance of the services pursuant to terms of the customer order. When payment is contingent upon customer acceptance of the installed system, revenue is deferred until such acceptance is received and installation completed.
Costs and Expenses
Contract costs include all direct material, direct labor costs, manufacturing overhead and other direct costs related to contract performance. Selling, general and administrative costs are charged to expense as incurred.
Inventory
In accordance with industry practice, inventoried costs contain amounts relating to contracts and programs with long production cycles, a portion of which will not be realized within one year. Inventory write downs are established for slow-moving, obsolete items and costs incurred on programs for which production-level orders cannot be determined as probable. Such write downs are based upon management’s experience and expectations for future business. Any changes arising from revised expectations are reflected in cost of sales in the period the revision is made.
Marketable Securities
All of the Company’s investments in marketable securities are Level 1 securities which trade on public markets and have current prices that are readily available. In general, investments in fixed price securities are only in the commercial paper of financially sound corporations or the bonds of U.S. Government agencies. Although the value of such investments may fluctuate significantly based on economic factors, the Company’s own financial strength enables it to wait for the securities to either recover their value or to mature such that any interim unrealized gains or losses are deemed to be temporary.
RESULTS OF OPERATIONS
The table below sets forth for the respective periods of fiscal years 2017 and 2016 (which end on April 30, 2017 and 2016, respectively) the percentage of consolidated revenues represented by certain items in the Company’s consolidated statements of operations:
| Revenues | Nine months Periods ended January 31, 2017 | 2016 | Three months 2017 | 2016 |
|---|---|---|---|---|
| FEI-NY | 71.3% | 76.4% | 73.9% | 72.0% |
| Gillam-FEI | 10.8 | 8.4 | 11.3 | 11.7 |
| FEI-Zyfer | 24.8 | 17.3 | 22.5 | 18.4 |
| Less intersegment revenues | (6.9) | (2.1) | (7.7) | (2.1) |
| 100.0 | 100.0 | 100.0 | 100.0 | |
| Cost of revenues | 68.6 | 66.0 | 70.9 | 65.0 |
| Gross margin | 31.4 | 34.0 | 29.1 | 35.0 |
| Selling and administrative expenses | 26.0 | 21.8 | 25.8 | 23.3 |
| Research and development expenses | 13.5 | 9.5 | 10.7 | 9.6 |
| Operating (loss) profit | (8.1) | 2.7 | (7.4) | 2.1 |
| Other income, net | 0.8 | 1.6 | 0.8 | 0.2 |
| Pretax (loss) income | (7.3) | 4.3 | (6.6) | 2.3 |
| (Benefit) provision for income taxes | (3.7) | 1.9 | (9.3) | 0.2 |
| Net (loss) income | (3.6)% | 2.4% | 2.7% | 2.1% |
15
Revenues
| Segment | Nine months Periods ended January 31, 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|---|
| FEI-NY | $27,176 | $35,306 | $(8,130) | (23%) | $9,461 | $9,719 | $(258) | (3%) |
| Gillam-FEI | 4,109 | 3,862 | 247 | 6% | 1,440 | 1,577 | (137) | (9%) |
| FEI-Zyfer | 9,473 | 7,979 | 1,494 | 19% | 2,877 | 2,482 | 395 | 16% |
| Intersegment revenues | (2,640) | (965) | (1,675) | NM% | (982) | (280) | (702) | NM% |
| $38,118 | $46,182 | $(8,064) | (17)% | $12,796 | $13,498 | $(702) | (5%) |
For the nine months ended January 31, 2017, revenues from commercial and U.S. Government satellite programs accounted for approximately 44% of consolidated revenues, compared to 58% of consolidated revenues for the same period of fiscal year 2016. For the three months ended January 31, 2017, revenues from commercial and U.S. Government satellite programs accounted for approximately 49% of consolidated revenues, compared to 59% of consolidated revenues for the same period of fiscal year 2016. Revenues from this business area decreased by approximately $10.1 million year over year. The primary reason for the reduction of revenues is additional delays in awards of certain satellite programs, particularly US government programs. Over short term intervals of time it is hard to predict the timing of major satellite procurements from the Company’s primary customers which are the major tier 1 satellite manufacturers and integrators. Revenues on these contracts are recognized primarily under the percentage of completion method. Revenues from the satellite market are recorded in the FEI-NY segment. U.S. Government/DOD revenues from non-space customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, rose by approximately $2.0 million compared to the same period of fiscal year 2017, and accounted for approximately 34% of consolidated revenues compared to approximately 23% for the same period in fiscal year 2016. FEI-Zyfer’s product mix consists primarily of secure communications products. Network infrastructure and other industrial revenues in the fiscal year 2017 periods accounted for approximately 22% of consolidated revenues compared to 18% in the prior year. Intersegment sales are eliminated in consolidation and have no effect on consolidated revenues. The downturn in satellite revenues from both commercial and government end users over the past several quarters is predominately due to satellite operators addressing new technology to incorporate in existing and new space programs. These new technologies afford more bandwidth and higher video resolution opportunities for satellite service providers and accordingly generate revisions and postponements of plans in order to incorporate improvements.
For the nine and three months ended January 31, 2016 and 2015, revenues from commercial and U.S. Government satellite programs accounted for approximately 60% of consolidated revenues. For the nine and three months ended January 31, 2016 satellite payload revenue has decreased by over $8 million and $3 million respectively, compared to the same periods in fiscal 2015, due primarily to delays in new contract awards for many of which the Company is the sole-source provider. This is due to unanticipated shifts in U.S. Government/DOD authorization and funding decisions during the current budget year. Revenues on these contracts are recognized primarily under the percentage of completion method and recorded in the FEI-NY segment. Revenues from non-space U.S. Government/DOD customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, for the nine-month period ended January 31, 2016 and 2015, accounted for approximately 20%, of consolidated revenues and for the three months then ended, were approximately 20% and 25% of consolidated revenues, respectively. The main factor affecting this segment is a delay in contract awards and shipments. Total revenues from U.S. Government satellite contracts and non-space programs for the nine and three months ended January 31, 2016 were approximately 60% and 55%, respectively, of consolidated revenues. Revenues from non-space U.S. Government/DOD customers are expected to increase, particularly for the FEI-Zyfer segment as it receives funding on several significant U.S. Government programs. Network infrastructure and other industrial revenues in the fiscal year 2016 periods accounted for approximately 20% of consolidated revenues which is similar to their share of consolidated revenues in the prior year. For the nine and three month periods ended January 31, 2016, these commercial revenues decreased by approximately $3.6 million and $0.6 million, respectively, as compared to the same periods of fiscal year 2015. The primary reasons for reduced revenue from this market area are due to lower third-party contract manufacturing revenues in the Company’s FEI-Asia subsidiary which is part of the FEI-NY segment and reduced sales volume at the Gilliam-FEI segment. In addition, in fiscal year 2016 periods, Gillam-FEI recorded lower intersegment revenues as compared to the prior year. Such intersegment sales are eliminated in consolidation and have no effect on consolidated revenues.
Gross margin
| Nine months Periods ended January 31, 2017 | 2016 | Change | Three months 2017 | 2016 | Change | |||
|---|---|---|---|---|---|---|---|---|
| $11,951 | $15,723 | $(3,772) | (24)% | $3,725 | $4,725 | $(1,000) | (21)% | |
| GM Rate | 31.4% | 34.0% | 29.1% | 35.0% |
Gross margin for the nine and three month periods ended January 31, 2017, decreased over the same period in fiscal year 2016 due primarily to lower revenues along with certain additional warranty costs from the satellite payload market recorded in the FEI-NY segment. In addition, FEI-Zyfer’s new product mix gave rise to higher initial integration and non-recurring engineering costs adding additional pressure on margin. The prior nine-month period ended January 31, 2016, included reimbursement from a vendor which improved the consolidated gross margin rate by approximately 1%.
Gross margin for the nine and three month periods ended January 31, 2016, decreased over the same period in fiscal year 2015 due primarily to lower revenues from the satellite payload market recorded in the FEI-NY segment. During the nine-month period ended January 31, 2016, the Company received reimbursement from a vendor which partially offset higher engineering and production costs incurred on certain programs impacted by a defective part. The cost reimbursement improved the consolidated gross margin rate by approximately 1%. During the nine and three months ending January 31, 2016, product mix is also a contributing factor to the increased profit margin rate.
Selling and administrative expenses
Periods ended January 31,
| Nine months 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|
| $9,893 | $10,067 | $(174) | (2)% | $3,296 | $3,151 | $145 | 5% |
For the nine-month period ended January 31, 2017 and 2016, selling and administrative expenses (“SG&A”) were approximately 26% and 22%, respectively, of consolidated revenues and for the three months then ended, were approximately 26% and 23% of consolidated revenues, respectively. The higher expense ratios in fiscal year 2017 periods are mainly due to lower revenues. Deferred compensation, legal and professional fees expenses increased offset by decreases in incentive compensation and stock option expenses.
Research and development expenses
Periods ended January 31,
| Nine months 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|
| $5,147 | $4,395 | $752 | 17% | $1,375 | $1,302 | $73 | 6% |
Research and development (“R&D”) expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and enhance competitiveness for future revenues. R&D spending for the nine months ended January 31, 2017, increased by approximately $750,000 to roughly 13.5% of consolidated revenues from 9.5% of consolidated revenues for the same period last fiscal year as the Company accelerated development on certain products for the satellite market as well as making product design and process improvements to enhance product manufacturability and reduce production costs. During periods of lower customer demand the Company can and will allocate increased available engineering resources to necessary R&D projects. Internal R&D spending includes continued development of new satellite payload microwave receivers/converters from DC to Ka band, improvement of quartz-based and rubidium atomic clocks, development of new GPS-based synchronization products improvement of ultra-low phase noise synthesizers and further enhancement of the capabilities of the Company’s line of low g-sensitivity and ruggedized rubidium oscillators.
Operating (loss) profit
Periods ended January 31,
| Nine months 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|
| $(3,089) | $1,261 | $(4,350) | NM% | $(946) | $272 | $(1,218) | NM% |
Lower gross margins on reduced consolidated revenues coupled with higher R&D spending resulted in decreased operating profits for the fiscal year 2017 periods as compared to the same periods in fiscal year 2016.
Other income (expense)
| Nine months Periods ended January 31, 2017 | 2016 | Change | Three months 2017 | 2016 | Change | |||
|---|---|---|---|---|---|---|---|---|
| Investment income | $387 | $408 | $(21) | (5)% | $108 | $43 | $65 | 151% |
| Interest expense | (128) | (93) | (35) | (38)% | (61) | (37) | (24) | (65)% |
| Other income (expense), net | 46 | 428 | (382) | (89)% | 49 | 24 | 25 | 104% |
| $305 | $743 | $(438) | (59)% | $96 | $30 | $66 | 223% |
Investment income is derived primarily from the Company’s holdings of marketable securities. Earnings on these securities may vary based on fluctuating interest rates and dividend payout levels and the timing of purchases or sales of securities. During the nine months ended January 31, 2017 and 2016, the Company recorded a gain of approximately $14,000 and $131,000, respectively, on the sale of certain marketable securities. During the first quarter of fiscal year 2016, the Company recognized a gain of approximately $400,000 from the proceeds of a life insurance policy upon the death of a former officer of the Company.
Income tax provision
Periods ended January 31,
| Nine months 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|
| $(1,392) | $900 | $(2,292) | NM% | $(1,188) | $20 | $(1,208) | NM% |
| Effective tax rate on pre-tax book income (loss): | |||||||
| 50.0% | 44.9% | 139.8% | 6.6% |
The effective tax rate for the nine months ended January 31, 2017 was 50% compared to 44.9% in the nine months ended January 31, 2016. For the three months ended January 31, 2017 and 2016, the effective tax rates were 139.8% and 6.6%, respectively. The current effective tax rates for the nine and three months ended January 31, 2017, reflect a tax benefit for losses generated by domestic operations as well as the impact of deductible permanent differences between book and taxable income. The increase in the effective tax rates compared to the prior periods is primarily due to changes in the earnings mix between U.S. and non-domestic operations and a U.S. tax deduction relating to the realization of the excess tax basis in common shares of FEI-Asia. During the three months ended January 31, 2017, the Company made a tax election to treat FEI-Asia a disregarded entity for U.S. tax purposes. Consequently, the Company recorded an income tax benefit of $1,392 and $1,188, respectively, compared to an income tax provision of $900 and $20 recorded in the respective nine and three month periods ended January 31, 2017 and 2016, respectively.
The Company’s projected annual effective tax rate is higher than the federal statutory rate of 34% primarily due to the impact of deductible permanent differences between book and tax income included in the computation of U.S. taxable income. The Company utilized R&D credits as well as the deduction relating to its investment in FEI-Asia during the nine and three months ended January 31, 2017 to lower its effective tax rate. The Company does not recognize an income tax benefit on pretax losses generated by its non-domestic operations.
Net (loss) income
Periods ended January 31,
| Nine months 2017 | 2016 | Change | Three months 2017 | 2016 | Change | ||
|---|---|---|---|---|---|---|---|
| $(1,392) | $1,104 | $(2,496) | NM% | $338 | $282 | $56 | 20% |
As detailed above, operating profits and pretax income were lower for the period ended January 31, 2017 as compared to the same periods of fiscal year 2016 resulting in reduced net income for the period ended January 31, 2017.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s balance sheet continues to reflect a strong working capital position of $69.3 million at January 31, 2017 and $75.6 million at April 30, 2016. Included in working capital at January 31, 2017 and April 30 2016, is $10.7 million and $17.2 million, respectively, consisting of cash, cash equivalents and marketable securities. The Company’s current ratio at January 31, 2017 is 11.8 to 1.
Net cash provided by operating activities for the nine months ended January 31, 2017 and 2016, were $2.6 million and $2.0 million respectively. The increased cash flow in the fiscal year 2017 period resulted primarily from a decrease in accounts receivable and a tax benefit related to a U.S. deduction related to the Company’s investment in FEI-Asia. The increased cash flow in the fiscal year 2016 period resulted primarily from collection of accounts receivable. For the nine month periods ended January 31, 2017 and 2016, the Company incurred approximately $4.1 million and $2.9 million, respectively, of non-cash operating expenses such as depreciation and amortization and accruals for employee benefit programs.
Net cash provided by investing activities for the nine months ended January 31, 2017 was $53,000 compared to $1,829,000 net cash used in investing activities in the same period of fiscal year 2016. During the fiscal year 2017 period, marketable securities were sold or redemptions in the amount of approximately $3.9 million compared to approximately $1.2 million of such redemptions during the fiscal year 2016 period. In the fiscal quarters ended January 31, 2017 and 2016, the Company acquired property, plant and equipment in the amount of approximately $3.8 million and $1.6 million, respectively. The Company may continue to invest cash equivalents in longer-term securities or to convert short-term investments to cash equivalents as dictated by its investment and acquisition strategies. The Company will continue to acquire more efficient equipment to automate its production process. The Company expects to spend between $3.5 million and $4.0 million on capital equipment during fiscal year 2017.
For the nine months ended January 31, 2017, net cash used in financing activities was approximately $6.0 million compared to $8,000 provided by financing activities for the nine months ended January 31, 2016. For the nine months ended January 31, 2017 and 2016, the Company realized $25,000 and $8,000, respectively, from the tax benefits arising from the exercise of stock-based awards. During the three months ended January 31, 2017, the Company repaid the Note payable of $6 million related to the Line of Credit with JPMorgan that has subsequently been terminated. There was an additional repayment of a loan by Gilliam-FEI in the same period. There were no additional borrowings or repayments for the full fiscal year 2016.
The Company has been authorized by its Board of Directors to repurchase up to $5 million worth of shares of its common stock for treasury whenever appropriate opportunities arise, but it has neither a formal repurchase plan nor commitments to purchase additional shares in the future. As of January 31, 2017, the Company has repurchased approximately $4 million of its common stock out of the $5 million authorization. For the nine months ended January 31, 2017 and 2016, there were no repurchases of shares.
The Company will continue to expend resources to develop, improve and acquire products for space applications, guidance and targeting systems, and communication systems, which management believes will result in future growth and continued profitability. During fiscal year 2017, the Company still intends to make a substantial investment of capital and technical resources to develop and acquire new products to meet the needs of the U.S. Government and commercial space and network infrastructure marketplaces and to invest in more efficient product designs and manufacturing procedures. Where possible, the Company will secure partial customer funding for such development efforts, but is targeting to spend its own funds at a rate of less than 10% of revenues to achieve its development goals. Internally generated cash will be adequate to fund these development efforts. The Company may also pursue acquisitions to expand its range of products and may use internally generated cash and external funding in connection with such acquisitions.
As of January 31, 2017, the Company’s consolidated funded backlog is approximately $42 million compared to $32 million at April 30, 2016 (the last day of fiscal year 2016.) Approximately 71% of this backlog is expected to be realized in the next twelve months. Included in the backlog at January 31, 2017 is approximately $8.0 million under cost-plus-fee contracts which the Company believes represent firm commitments from its customers for which the Company has not received full funding to-date. The Company excludes from backlog any contracts or awards for which it has not received authorization to proceed and on fixed price contracts excludes any unfunded portion. The Company expects these contracts to become fully funded over time and will add to its backlog at that time.
The Company believes that its liquidity is adequate to meet its operating and investment needs through the end of March 2018.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements, other than operating leases, that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Controls and procedures
As filed, 1,729 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on their evaluation, the Company’s chief executive officer and chief financial officer have concluded that, as of January 31, 2017, the Company’s disclosure controls and procedures were effective to ensure that information relating to the Company, including its consolidated subsidiaries, required to be included in its reports that it filed or submitted under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended January 31, 2017 to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-11-01 to 2017-01-31 | $12.8m | us-gaap:Revenues |
| Revenue | 9 months2016-05-01 to 2017-01-31 | $38.1m | us-gaap:Revenues |
| Cost of revenue | 3 months2016-11-01 to 2017-01-31 | $9.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2016-05-01 to 2017-01-31 | $26.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-11-01 to 2017-01-31 | $3.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-05-01 to 2017-01-31 | $12.0m | us-gaap:GrossProfit |
| Research and development | 3 months2016-11-01 to 2017-01-31 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-05-01 to 2017-01-31 | $5.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-11-01 to 2017-01-31 | $3.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-05-01 to 2017-01-31 | $9.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-11-01 to 2017-01-31 | −$946.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-05-01 to 2017-01-31 | −$3.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-11-01 to 2017-01-31 | $61.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2016-05-01 to 2017-01-31 | $128.0k | us-gaap:InterestExpense |
| Income tax | 3 months2016-11-01 to 2017-01-31 | −$1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-05-01 to 2017-01-31 | −$1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-11-01 to 2017-01-31 | $338.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-05-01 to 2017-01-31 | −$1.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-11-01 to 2017-01-31 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-05-01 to 2017-01-31 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-11-01 to 2017-01-31 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-05-01 to 2017-01-31 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-11-01 to 2017-01-31 | 8,979,987 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-05-01 to 2017-01-31 | 8,780,069 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2016-05-01 to 2017-01-31 | $2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-05-01 to 2017-01-31 | $3.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-01-31 | $3.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-01-31 | $75.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-01-31 | $112.8m | us-gaap:Assets |
| Current liabilities | At period end2017-01-31 | $6.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-01-31 | $19.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-01-31 | $93.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001185185-17-000591. Last ingested by Listed: Nov 5, 2026, 18:05 ET. Listed shows no prices and gives no investment advice.